HPTN 083: Injectable PrEP can make breakthrough infections hard to detect
Reformulated islatravir implant should provide PrEP for over a year
Once-a-month PrEP pill easily passes its first big test
Study finds diabetes is associated with a 25% reduction in concentration of tenofovir in blood spot samples, but what are the causes and consequences?
New once-a-week drug could be part of weekly oral treatment
Genetics may contribute to weight gain after switching from efavirenz to an integrase inhibitor
Adult doses of dolutegravir can be used by children weighing 20 kg or more
Trans and cis women and men all have similar levels of PrEP drugs in blood, directly observed dosing study finds
Fewer antiretroviral drug interactions due to use of integrase inhibitors, says Swiss study
